4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001104659-22-120752
Director acquired 139 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Drutz David · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-18 | Exercise or conversion : show line 1 in the form | +139 | $2.40 | $334 | 20,151 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-11-18 | Exercise or conversion : show line 2 in the form Stock Options (option to buy) | −139 | 0 | D |
Loading xslF345X03/tm2231089-1_4seq1.xml…